Eli Lilly remains optimistic about strong demand for its weight-loss and anti-diabetes injectable, tirzepatide (sold as Mounjaro), despite ...

Wegovy and Ozempic ⁠price cuts will be effective January 1 next year, coinciding with the implementation of new, lower prices for the same ...

Dr Reddy's Laboratories is set to launch a generic version of semaglutide in India on March 21. The company plans to offer both oral and in...

The Trump administration launched TrumpRx.gov on Thursday (February 5, 2026), a website designed to help Americans purchase prescription dr...

India's obesity drug market is experiencing rapid growth, driven by rising lifestyle diseases and the launch of blockbuster therapies. The ...

Novo Nordisk has slashed Wegovy prices in India by nearly 40 percent. This move has dramatically increased sales volume by 70 percent in No...

Danish drugmaker Novo Nordisk is set to launch its popular diabetes drug Ozempic in India this month. This move aims to capture a significa...

Novo Nordisk India head Vikrant Shrotriya revealed a strategic 37% price cut for obesity drug Wegovy, aiming for wider accessibility. The c...

President Donald Trump announced TrumpRx, a government-operated website launching early 2026 for discounted prescription drugs. Pfizer agre...

As weight-loss drug sales surge with semaglutide's patent expiration, Gujarat's Shaily Engineering Plastics, an injector pen manufacturer, ...

The achievement of that goal in India, which ranks third in obesity numbers after the US and China, will shatter the record for prescriptio...

Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the US. Participant...

A new study into GLP-1RA drugs provides previously unknown insights into the impact this class of drugs may have on eating habits. The stud...

The startup claims that, unlike injectable drugs such as Ozempic and Mounjaro, which can have side effects, its solution is a non-invasive ...

The White House plans to contest a court ruling that blocked part of the Trump administration's directive to pause federal financial aid. A...

U.S. health insurance claims analysis shows that two years after starting Novo Nordisk's Wegovy or similar GLP-1 drugs, annual medical cost...

Berberine has become popular on social media as users have claimed that it aids in weight loss. Here are all the details related to Berberi...